Alumis Inc. (ALMS) stock
ALMSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.14−0.46 (-8.21%)
Close on Nov 16, 2026Market cap $665.30MP/E –Yield –
Alumis cash
Cash and short-term investments held at the end of each period.
Alumis's cash was $502.30M at Jun 30, 2026. For fiscal 2025 it was $308.50M, up 7.0% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $308.50M | +7.0% |
| FY2024 | Dec 31, 2024 | $288.30M | +475.6% |
| FY2023 | Dec 31, 2023 | $50.09M | +85.8% |
| FY2022 | Dec 31, 2022 | $26.95M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $502.30M | +3.3% |
| Q1 FY2026 | Mar 31, 2026 | $569.50M | +172.9% |
| Q4 FY2025 | Dec 31, 2025 | $308.50M | +7.0% |
| Q3 FY2025 | Sep 30, 2025 | $377.70M | +4.4% |
| Q2 FY2025 | Jun 30, 2025 | $486.30M | +132.1% |
| Q1 FY2025 | Mar 31, 2025 | $208.70M | +86.2% |
| Q4 FY2024 | Dec 31, 2024 | $288.30M | +475.6% |
| Q3 FY2024 | Sep 30, 2024 | $361.90M | +571.0% |
| Q2 FY2024 | Jun 30, 2024 | $209.50M | +163.3% |
| Q1 FY2024 | Mar 31, 2024 | $112.07M | +315.8% |
| Q4 FY2023 | Dec 31, 2023 | $50.09M | – |
| Q3 FY2023 | Sep 30, 2023 | $53.94M | – |
| Q2 FY2023 | Jun 30, 2023 | $79.56M | – |
| Q4 FY2022 | Dec 31, 2022 | $26.95M | – |
See a number that looks wrong?